Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Published in: Familial Cancer 2/2018

01-04-2018 | Erratum

Erratum to: A new hereditary colorectal cancer network in the Middle East and eastern Mediterranean countries to improve care for high-risk families

Authors: Zeinab Ghorbanoghli, Carol Jabari, Walid Sweidan, Wail Hammoudeh, George Cortas, Ala I. Sharara, Amal Abedrabbo, Ijad Hourani, Bahareh Mahjoubi, Keivan Majidzadeh, Nurdan Tözün, Hadia Ziada-Bouchaar, Waseem Hamoudi, Osama Diab, Hamid Reza Khorram Khorshid, Henry Lynch, Hans Vasen

Published in: Familial Cancer | Issue 2/2018

Login to get access

Excerpt

Unfortunately, the 10th author name in the author group was published incorrectly in the original publication as “Keivan Maijdzadeh” the correct name is: Keivan Majidzadeh. …
Metadata
Title
Erratum to: A new hereditary colorectal cancer network in the Middle East and eastern Mediterranean countries to improve care for high-risk families
Authors
Zeinab Ghorbanoghli
Carol Jabari
Walid Sweidan
Wail Hammoudeh
George Cortas
Ala I. Sharara
Amal Abedrabbo
Ijad Hourani
Bahareh Mahjoubi
Keivan Majidzadeh
Nurdan Tözün
Hadia Ziada-Bouchaar
Waseem Hamoudi
Osama Diab
Hamid Reza Khorram Khorshid
Henry Lynch
Hans Vasen
Publication date
01-04-2018
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 2/2018
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-017-0023-9

Other articles of this Issue 2/2018

Familial Cancer 2/2018 Go to the issue

Original Article

p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers

Original Article

Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic

Original Article

The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes

Review

Pancreatic neuroendocrine tumor in a patient with a TSC1 variant: case report and review of the literature

Original Article

A comparison of cosegregation analysis methods for the clinical setting

Short Communication

Immunohistochemical null-phenotype for mismatch repair proteins in colonic carcinoma associated with concurrent MLH1 hypermethylation and MSH2 somatic mutations
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits